A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children

Figure 1

Characterizing hypoxia risk signatures in osteosarcoma to assess mortality and clinical outcomes: (a, b) development of a hypoxia susceptibility signature to assess children with osteosarcoma prognosis through univariate and multivariate Cox analyses; (c, d) Spearman relation study of a four-gene signature in TARGET and GEO databases.

(a)

(b)

(c)

(d)